Coronavirus BRIEFING
Supported by Essilor

The National Average for Gross Revenue at ECP Locations Remained Flat for the Week of April 1–7, Jobson’s Latest Practice Performance Tracker Shows

By Staff
Wednesday, April 10, 2024 12:24 AM NEW YORK—The national average for gross revenue at ECP locations remained flat last week, April 1–7, when compared with the previous week. That places gross revenue at a level -1 index point below where it was at this point in time (Week 14) when compared with last year (2023), 3 points above the same period in 2022, 10 points above 2021, 103 points above 2020 and 16 points above 2019, according to Jobson’s most recent Practice Performance Tracker.

For Some MDs, Long COVID Burnout Is a New Reality

By Staff
Monday, April 8, 2024 8:02 AM Dhaval Desai, MD, was teaching his 4-year-old to ride a bike after another exhausting shift at the hospital during the summer after the first COVID-19 surge. He was putting on a happy face and forcing out a "Yay!" he did not feel. The pandemic had taken its toll, and he just wanted to lie down and be alone. Realizing that he was "scraping to find joy" was when he knew something was wrong.

Study Shows Nirmatrelvir–Ritonavir No More Effective Than Placebo for COVID-19 Symptom Relief

By Staff
Monday, April 8, 2024 8:02 AM Paxlovid does not significantly alleviate symptoms of COVID-19 compared with placebo among nonhospitalized adults, a new study published on April 3 in The New England Journal of Medicine found.

How Therapy Can Help During Life-Changing Events Like COVID

By Staff
Thursday, April 4, 2024 7:59 AM When the COVID-19 pandemic hit 4 years ago, Jenn Kearney felt extra thankful for her years of therapy. The 34-year-old digital communications manager from Boston said her 11 years of doing therapy, specifically cognitive behavioral therapy, or CBT, prior to the pandemic had given her skills and “ways to cope and adapt that not only benefited me, but the people around me,” she said.

Paxlovid Fails to Shorten COVID in Standard-Risk and Vaccinated At-Risk Patients

By Staff
Thursday, April 4, 2024 6:09 AM Nirmatrelvir/ritonavir (Paxlovid) failed to shorten COVID-19 symptom duration among people at standard risk for severe COVID-19 and among vaccinated people with at least one risk factor for severe disease, according to final results of the phase II/III EPIC-SR.

Baby Formula Shortage Changed Parents’ Buying Habits, U.S. Census Bureau Reports

By Staff
Wednesday, April 3, 2024 11:55 AM A formula shortage in 2022 had parents scrambling to find alternative options for their babies. In 2022, a formula shortage due to the pandemic, product recalls and supply chain issues left grocery store shelves bare and parents in search of infant formula. 

A new report from the U.S. Census Bureau finds that more than 57.5 percent of parents had to switch stores in order to find baby formula in the fall of 2022, falling slightly to 57 percent by the summer of 2023. 

More than 20 percent of parents reported they were having a hard time finding formula in the summer of 2023, an improvement of more than 14 percentage points over the fall of 2022. 

The Census Bureau report found that between the dates of September 14 and October 17 in the fall of 2022, parents of infants or babies under 1 year were asked how they were coping with the shortage. More than 34 percent said they had difficulty getting formula during the previous seven days. By the summer of 2023, this number had fallen to just below 20 percent, signaling that the pandemic was no longer having the same impact on formula availability. 

Many parents reported they dealt with the shortfall by changing shopping behaviors, such as changing brands or types of formula. More than 55 percent of parents had changed formulas by the fall of 2022, improving to 44 percent by the summer of 2023. 

More than 32 percent of parents indicated that they had dealt with the shortage by receiving formula from family and friends, or “others.”

The National Average for Gross Revenue at ECP Locations Decreased for the Week of March 25–31, Jobson’s Latest Practice Performance Tracker Shows

By Staff
Wednesday, April 3, 2024 12:24 AM NEW YORK—The national average for gross revenue at ECP locations decreased last week, March 25–31, when compared with the previous week at a rate of -4 index points. That places gross revenue at a level -1 index point below where it was at this point in time (Week 13) when compared with last year (2023), 2 points above the same period in 2022, 4 points above 2021, 97 points above 2020 and 14 points above 2019, according to Jobson’s most recent Practice Performance Tracker.

Air Travel Is on the Rise as Passenger Traffic Begins to Surpass Pre-Pandemic Levels

By Staff
Tuesday, April 2, 2024 2:29 PM Americans are ready to return to the friendly skies. A new report from the Airport Councils International (ACI) indicates that global passenger travel will surpass 2019 levels in 2024, reaching more than 9.7 billion travelers. 

The increase is expected to be short-lived and will taper off over the next few years as markets recover from the impact of the pandemic. The ACI reported that macroeconomic factors, such as high global inflation, slowdown of global GDP, pessimistic business confidence levels and geopolitical conflicts continue to pose a risk to the recovery of air travel. 

Several regions are expected to see a significant influx in travel, including Africa where passenger rates are expected to grow from 219 million in 2013 to 242 million in 2024. It’s predicted it will grow even further in 2025 to 261 million. 

The North American region will have modest growth reaching 2.2 billion in 2024 with a small increase to 2.3 billion in 2025. This would be on par with pre-pandemic growth figures. 

The Middle East is expected to see modest growth over the next few years, climbing to 466 million in 2024 and 510 million in 2025; however, the ACI noted that geopolitical tension in the region could significantly affect these projections. 

Global passenger traffic is expected to grow at a rate of 4.3 percent over the next three years. Total passenger traffic could reach 25 billion by 2052.

Latest COVID Vax Cuts Hospitalization Risk in Immunocompromised People

By Staff
Tuesday, April 2, 2024 6:12 AM For adults who are immunocompromised, the updated 2023-2024 COVID-19 vaccine reduced risk of hospitalization compared with not getting the shot, according to CDC data.

Baseball Attendance Is on the Rise, MLB Reports

By Staff
Friday, March 29, 2024 1:52 PM Baseball season is in full swing, and experts are predicting a resurgence in attendance in 2024. Recent years saw attendance numbers slip due to the pandemic and the cancellation of games. 

In 2023, regular season attendance reached more than 70 million for the first time since 2017, according to Major League Baseball (MLB). Prior to the pandemic, regular season attendance had been on the decline, falling to just over 69 million in 2018. By 2019, it had fallen to 68.5 million, and it slipped again in 2022 to 64.5 million. The 2020 and 2021 seasons saw dozens of games canceled, along with some teams unable to travel due to players’ illness and COVID restrictions. 

Several new rules are slated for the 2024 season, including the widening of the runners' lane to include the dirt between the foul line and the infield grass. This will provide a more direct path from the right-handed batter’s box to first base. 

Pitch times have also been adjusted from 20 seconds to 18 seconds with runners on base. Meanwhile, mound visits will be reduced from five to four times in a game.

Pediatric Mental Health Was Stable Early in the Pandemic

By Staff
Friday, March 29, 2024 8:02 AM The mental health of children and adolescents was largely stable during the first year of the COVID-19 pandemic, but racial disparities in access to outpatient psychiatric care worsened, new research suggested.

Fauci: When Confronted With Misinformation, Stick to the Science

By Staff
Friday, March 29, 2024 6:15 AM While public health professionals don't get formal training on how to operate in highly politically charged and divisive environments, the best thing to do is stick to the facts, evidence, and data, Anthony Fauci, MD, former director of the National Institute of Allergy and Infectious Diseases (NIAID), told an audience of health policy graduate students on Wednesday.

New Data: Long COVID Cases Surge

By Staff
Thursday, March 28, 2024 8:02 AM Experts worry a recent rise in long COVID cases—fueled by a spike in winter holiday infections and a decline in masking and other measures—could continue into this year.

Health Workers Fear Profits May Trump Safety in New CDC Recommendations

By Staff
Wednesday, March 27, 2024 8:02 AM Four years after hospitals in New York City overflowed with COVID-19 patients, emergency physician Sonya Stokes remains shaken by how unprepared and misguided the American health system was.

The National Average for Gross Revenue at ECP Locations Increased for the Week of March 18–24, Jobson’s Latest Practice Performance Tracker Shows

By Staff
Wednesday, March 27, 2024 12:24 AM NEW YORK—The national average for gross revenue at ECP locations increased last week, March 18–24, when compared with the previous week at a rate of 1 index point. That places gross revenue at a level 5 index points above where it was at this point in time (Week 12) when compared with last year (2023), 11 points above the same period in 2022, 6 points above 2021, 54 points above 2020 (the first week of COVID lockdown restrictions) and 20 points above 2019, according to Jobson’s most recent Practice Performance Tracker.